Gleicher N
Center for Human Reproduction, Chicago, IL.
Hum Reprod. 1992 Jul;7(6):821-4. doi: 10.1093/oxfordjournals.humrep.a137743.
Endometriosis is generally regarded and treated as an endocrine and/or a surgical disease. Endocrine and surgical approaches to treatment are effective only in treating the symptoms of the disease and not its pathophysiology. Consequently, the success of such therapy is at best short-lived, and probably non-existent in mild disease. This thesis therefore argues for a new therapeutic approach towards endometriosis. In view of increasing evidence in favour of an immunological aetiology for this condition, it is suggested that such an approach may involve immunological rather than endocrine manipulation. It is also proposed that so-called unexplained infertility may in many cases represent a precursor stage of endometriosis, since immunological abnormalities in both of these conditions are so similar. Large-scale, prospective, multicentre clinical trials of immunotherapy in unexplained infertility and endometriosis appear to be indicated at this time if endometriosis is to lose its importance as one of the major contributors to female infertility.
子宫内膜异位症通常被视为一种内分泌疾病和/或外科疾病,并以此进行治疗。内分泌和外科治疗方法仅能有效缓解该疾病的症状,而非其病理生理过程。因此,此类治疗的效果至多是短暂的,对于轻度疾病可能根本无效。因此,本论文主张针对子宫内膜异位症采用一种新的治疗方法。鉴于越来越多的证据支持该病的免疫病因学,建议这种方法可能涉及免疫调节而非内分泌调节。还提出所谓的不明原因不孕症在许多情况下可能代表子宫内膜异位症的前驱阶段,因为这两种病症的免疫异常非常相似。如果子宫内膜异位症想要不再作为女性不孕的主要原因之一,此时似乎有必要针对不明原因不孕症和子宫内膜异位症开展大规模、前瞻性、多中心的免疫治疗临床试验。